Liquid Biopsy Holds Its Own in NSCLC

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2019-033
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Liquid Biopsy Holds Its Own in Tumor Profiling

Cancer Discovery
Oncology
2016English

Liquid Biopsy and Its Clinical Applications in Oncology

Journal of Evidence Based Medicine and Healthcare
2019English

Liquid Biopsy

Science
MultidisciplinaryPhilosophy of ScienceHistory
2010English

P2.13-28 Comparison of ddPCR and NGS in Liquid Biopsy to Pathology Results in EGFR-Mutated NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Liquid Biopsy in Non‐Hodgkin's Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Liquid Biopsy in Tissue-Born Lymphomas

Swiss Medical Weekly
Medicine
2019English

MA04.07 MicroRNA-Based Liquid Biopsy Combines With PD-L1 Tumor Expression to Predict Response to Immunotherapy in Advance NSCLC Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

The Future of Liquid Biopsy

Nature
Multidisciplinary
2020English

P1.01-67 Clinical Relevance of ALK/ROS1 Resistance Mutations and Other Acquired Mutations Detected by Liquid Biopsy in Advanced NSCLC Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy